一般社団法人日本呼吸器学会 公式サイト
日本呼吸器学会英文誌 Respiratory Investigation
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 検索用
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 全文PDF

Abstract

Full Text of PDF Full Text of PDF (349k)
Article in Japanese

Case Report

A case of non-small cell lung cancer with hypersensitivity reaction after long-term docetaxel treatment

Ren Seikea  Yusuke Takayamaa  Shun Takaoa  Shohei Mishimaa  Hiroyasu Shodaa  Yasuo Iwamotob 

aDepartment of Respiratory Medicine, Hiroshima City Hiroshima Citizens Hospital
bDepartment of Oncology, Hiroshima City Hiroshima Citizens Hospital

ABSTRACT

A 50-year-old female underwent chemotherapy with docetaxel as third-line therapy for postoperative recurrence of lung adenocarcinoma for about 10 years. She had a skin rash at the first dose of docetaxel but was able to continue the treatment with antihistamine premedication. In August 2021, she received the coronavirus disease 2019 (COVID-19) vaccine. After that, she was able to be administered the 129th course of docetaxel without any problems in August. However, she developed skin rash and dyspnea after the 130th and 131st courses of docetaxel, and the treatment was discontinued. Hypersensitivity reactions to taxanes usually occur in the early stages of treatment, but this patient developed a hypersensitivity reaction after long-term treatment, which was atypical. Docetaxel solvents such as polyethylene glycol and polysorbate 80 appeared to be responsible for the hypersensitivity reaction. We considered the influence of the COVID-19 vaccine administered about 2 months before the docetaxel treatment, and we report this case because it seemed to be a valuable one.

KEYWORDS

Docetaxel  Polyethylene glycol (PEG)  Polysorbate  Coronavirus disease 2019 (COVID-19) vaccine 

Received 28 Feb 2023 / Accepted 14 Jun 2023

AJRS, 12(5): 265-269, 2023

Google Scholar